Brief: Rubius Therapeutics Announces Strategic Update

Rubius Therapeutics

13/09/2022 12:02

Sept 13 (Reuters) - Rubius Therapeutics Inc  RUBY.O :
    * RUBIUS THERAPEUTICS ANNOUNCES STRATEGIC UPDATE
    * RUBIUS THERAPEUTICS INC - INITIATING COST-SAVING MEASURES
THROUGH CORPORATE RESTRUCTURING; CASH RUNWAY EXTENDED TO END OF
2023
    * RUBIUS THERAPEUTICS INC - DISCONTINUING ONGOING PHASE 1
CLINICAL
TRIALS OF RTX-240 AND RTX-224 IN ADVANCED SOLID TUMORS
    * RUBIUS THERAPEUTICS INC - TO FOCUS ON ADVANCING NEXT
GENERATION
RED BLOOD CELL-BASED CELL CONJUGATION PLATFORM
    * RUBIUS THERAPEUTICS - IMPLEMENTING A 75% REDUCTION IN
FORCE,
PRIMARILY FOCUSED ON CLINICAL DEVELOPMENT, MANUFACTURING AND
GENERAL AND ADMINISTRATIVE
    * RUBIUS THERAPEUTICS INC - EXPLORING SALE OF ITS
MANUFACTURING
FACILITY IN SMITHFIELD, RHODE ISLAND

Source text for Eikon:  ID:nGNX5Y0qNM 
Further company coverage:  RUBY.O 

 ((Reuters.Briefs@thomsonreuters.com;))